Heart transplants from donors with hepatitis C may be safe

By American Heart Association News

drbueller/E+, Getty Images
(drbueller/E+, Getty Images)

Transplants from donors with hepatitis C may be a safe option for those awaiting new hearts – a major development in curbing the nationwide organ shortage, according to new research.

Patients who received heart transplants from donors who had hepatitis C saw similar outcomes a year after surgery as those whose donors did not have hepatitis C. Researchers compared one-year survival, organ rejection, dialysis and incidence of stroke.

The study, published Wednesday in the Journal of the American Heart Association, examined 7,889 U.S. adults who received heart transplants between 2016 and 2018. Slightly more than 4%, or 343, received heart transplants from donors with hepatitis C.

"We are encouraged by these results and believe this is a landmark change in our ability to better meet the demand for heart transplantation by increasing the donor supply," Dr. Arman Kilic, lead study author, said in a news release. He is professor of cardiothoracic surgery at the University of Pittsburgh Medical Center in Pennsylvania. "It is our hope that more centers will use hepatitis C-positive donors for heart transplantation."

Hepatitis C, though curable in most cases, can be a debilitating illness. It is a viral liver infection that spreads through contact with contaminated blood, by way of shared needles and from mother to infant during pregnancy and delivery. Because it can be treated, there has been an increase in organ donors with hepatitis C as the need for heart transplants continues to exceed the supply.

In the new study, researchers found similar survival rates regardless of whether patients received a heart from a donor with or without hepatitis C – 90% compared to 91%, respectively. There was also little difference between the two groups when comparing the rates of stroke, drug-treated organ rejection, and kidney dialysis to remove toxins from the blood.

More than 6 million people in the U.S. have heart failure and more than 900,000 new cases are diagnosed each year. It occurs when other types of heart disease weaken the heart until it is unable to pump blood effectively throughout the body. Although lifestyle changes and medications can help manage mild heart failure, severe cases may require a heart transplant.

The study did have limitations. For example, researchers did not collect information about the type of hepatitis C infection each donor had or past treatments they received. The study also did not report whether transplant recipients developed the infection.

If you have questions or comments about this story, please email editor@heart.org.


American Heart Association News Stories

American Heart Association News covers heart disease, stroke and related health issues. Not all views expressed in American Heart Association News stories reflect the official position of the American Heart Association.

Copyright is owned or held by the American Heart Association, Inc., and all rights are reserved. Permission is granted, at no cost and without need for further request, to link to, quote, excerpt or reprint from these stories in any medium as long as no text is altered and proper attribution is made to the American Heart Association News. See full terms of use.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.